-
Clinical Trial
In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo.
- Ahmad Masri and Van SpallHarriette G CHGCMcMaster University, Hamilton, Ontario, Canada (H.G.V.)..
- Oregon Health & Science University, Portland, Oregon, USA (A.M.).
- Ann. Intern. Med. 2024 Mar 1; 177 (3): JC30JC30.
AbstractMaurer MS, Kale P, Fontana M, et al; APOLLO-B Trial Investigators. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med. 2023;389:1553-1565. 37888916.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..